NUREG-0825: Difference between revisions

From kanterella
Jump to navigation Jump to search
(StriderTol Bot change)
(StriderTol Bot change)
Line 1: Line 1:
#REDIRECT [[NUREG-0825, Summary of 860806-14 Meetings W/Util,Lll,Eg&G & Cygna Corp in San Francisco,Ca Re Resolution of SEP (NUREG-0825) Reevaluation.Unresolved Issues,Performance of Audits & case-by-case Reviews & Confirmatory Analysis Discussed]]
#REDIRECT [[NUREG-0825, Safety Evaluation on Util 830316 Assessment & Proposed Corrective Actions for NUREG-0825,Section 4.22 Re Containment Isolation Sys.Containment Isolation Provisions Acceptable]]

Revision as of 11:37, 28 December 2020